BIOMAT Database Logo BIOMAT Database Logo

Acute respiratory distress syndrome caused by Mycoplasma pneumoniae diagnosed by polymerase chain reaction. 2012

Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
Regional Virus Laboratory, Royal Victoria Hospital, Belfast Health and Social Care Trust Grosvenor Road, Belfast BT12 6BA.

Mycoplasma pneumoniae (M. pneumoniae) is a common pathogen in cases of atypical pneumonia. Most individuals with Mycoplasma pneumonia run a benign course, with non-specific symptoms of malaise, fever and non-productive cough that usually resolve with no long-term sequelae. Acute lung injury is not commonly seen in Mycoplasma pneumonia. We report a case of acute respiratory distress syndrome cause by M. pneumoniae diagnosed by quantitative real-time polymerase chain reaction (RT-PCR).

UI MeSH Term Description Entries
D009177 Mycoplasma pneumoniae Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man. Eaton Agent
D011019 Pneumonia, Mycoplasma Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR. Mycoplasma Pneumonia,Pneumonia, Primary Atypical,Mycoplasma dispar Infection,Mycoplasma ovipneumoniae Infection,Mycoplasma pneumoniae Infection,Atypical Pneumonia, Primary,Atypical Pneumonias, Primary,Mycoplasma Pneumonias,Mycoplasma dispar Infections,Mycoplasma ovipneumoniae Infections,Mycoplasma pneumoniae Infections,Pneumonias, Mycoplasma,Pneumonias, Primary Atypical,Primary Atypical Pneumonia,Primary Atypical Pneumonias
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
Fatal encephalitis caused by Mycoplasma pneumoniae diagnosed by the polymerase chain reaction.
December 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
Adult respiratory distress syndrome caused by Mycoplasma pneumoniae.
October 1978, Chest,
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
[Mycoplasma pneumoniae pneumonia and acute respiratory distress syndrome].
October 2006, Anales de medicina interna (Madrid, Spain : 1984),
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
Acute respiratory distress syndrome related to Mycoplasma pneumoniae infection.
January 2017, Respiratory medicine case reports,
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
Polymerase chain reaction evaluation for Mycoplasma pneumoniae.
October 1997, The Journal of infectious diseases,
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
Infected abdominal aortic aneurysm caused by Streptococcus pneumoniae diagnosed using polymerase chain reaction.
December 2015, Surgical case reports,
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
Acute respiratory distress syndrome caused by Mycoplasma pneumoniae without elevated pulmonary vascular permeability: a case report.
May 2016, Journal of thoracic disease,
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
Detection of Mycoplasma pneumoniae by using the polymerase chain reaction.
November 1989, Journal of clinical microbiology,
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
[Rapid detection method for Mycoplasma pneumoniae by polymerase chain reaction].
July 1992, Nihon rinsho. Japanese journal of clinical medicine,
Peter Yew, and David Farren, and Tanya Curran, and Peter V Coyle, and Conall McCaughey, and Lorcan McGarvey
[Rhabdomyolysis in Mycoplasma pneumoniae infection with acute respiratory distress syndrome].
April 1984, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!